HHS tracking drugs made in China; global coronavirus cases increase

Feb 26, 2020 - 02:43 PM
Coronavirus Update 900x400

The Department of Health and Human Services is aware of 20 pharmaceutical products made or with a critical active ingredient solely sourced in China, but to date is not aware of any expected shortages, HHS Secretary Alex Azar told House appropriators today. He said the agency knows of two pharmaceutical makers in Hubei Province, the epicenter of the novel coronavirus (COVID-19) outbreak, but they have a large stockpile supply of advance production.

For the first time since the outbreak started, more new cases are being reported outside China than from China, the World Health Organization said today. While China continues to have the most cases overall, there are now confirmed COVID-19 cases on every continent except Antarctica, totaling more than 81,000 in 37 countries.

The Centers for Disease Control and Prevention continues to update resources, including interim guidance for businesses and employers to plan and respond to COVID-19.

For the latest information and resources, visit AHA’s coronavirus webpage.

Related News Articles

Headline
CDC reports 2022 drug-resistant infections remained above pre-pandemic levels 
Antimicrobial-resistant infections remained above pre-pandemic levels in 2022, the Centers for Disease Control and Prevention reported July 16. CDC data show…
Headline
CDC confirms four human cases of bird flu at Colorado poultry facility 
The Centers for Disease Control and Prevention July 14 announced four confirmed human cases of H5N1 bird flu among farm workers who were working at a Colorado…
Headline
ASPR announces pandemic strategy to support bird flu threat to humans 
The Administration for Strategic Preparedness and Response June 25 announced a flu pandemic preparedness and response strategy in response to the threat of…
Headline
CDC issues alert on increased risk of dengue infections in the U.S.
The Centers for Disease Control and Prevention June 25 issued a Health Alert Network Health Advisory about an increased risk of dengue virus infections in the…
Headline
FDA grants enforcement discretion for use of conjunctival swabs to test for bird flu in humans
The Food and Drug Administration last week granted enforcement discretion for the use of conjunctival swabs by laboratories as part of human testing for H5N1…
Headline
CDC recommends flu surveillance operations remain elevated for potential human H5N1 bird flu cases
The Centers for Disease Control and Prevention May 21 announced recommendations that flu surveillance systems continue operating at enhanced levels during the…